Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420–9.
Jessurun J. Helicobacter pylori: an evolutionary perspective. Histopathology. 2021;78(1):39–47.
Navashenaq JG, Shabgah AG, Banach M, et al. The interaction of helicobacter pylori with cancer immunomodulatory stromal cells: New insight into gastric cancer pathogenesis. Semin Cancer Biol. 2021;86(Pt 3):951–9.
Watari J, Chen N, Amenta PS, et al. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol. 2014;20(18):5461–73.
CAS PubMed PubMed Central Google Scholar
Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of antibiotic resistance in helicobacter pylori: a systematic review and meta-analysis in world health organization regions. Gastroenterology. 2018;155(5):1372-1382.e1317.
Li Y, Li X, Tan Z. An overview of traditional Chinese medicine therapy for Helicobacter pylori-related gastritis. Helicobacter. 2021;26(3): e12799.
Liu WZ, Xie Y, Lu H, et al. Fifth Chinese national consensus report on the management of helicobacter pylori infection. Helicobacter. 2018;23(2): e12475.
Li L, Meng F, Zhu S, et al. Efficacy and safety of Wei Bi Mei, a Chinese herb compound, as an alternative to bismuth for eradication of helicobacter pylori. Evid Based Complement Alternat Med. 2018;2018:4320219.
PubMed PubMed Central Google Scholar
Li RJ, Dai YY, Qin C, et al. Application of traditional Chinese medicine in treatment of Helicobacter pylori infection. World J Clin Cases. 2021;9(35):10781–91.
PubMed PubMed Central Google Scholar
Zuskin E, Lipozencić J, Pucarin-Cvetković J, et al. Ancient medicine–a review. Acta Dermatovenerol Croat. 2008;16(3):149–57.
Hai J. Effect of western medicine triple combination combined with Tibetan medicine Zuozhu-Daxi pill on improving gastrointestinal function and serum CRP and IL-4 levels in the treatment of peptic ulcer. Chin J Ethnic Med. 2022;28(2):7–8.
Hu W. Clinical observation on the treatment of digestive tract tumor vomiting after chemotherapy with Zuozhu-Daxi combined with Astragalus injection and Xiaobanxia pill. Jilin Medical J. 2011;32(8):1500–1.
Baj J, Korona-Glowniak I, Forma A, et al. Mechanisms of the epithelial-mesenchymal transition and tumor microenvironment in helicobacter pylori-induced gastric cancer. Cells. 2020;9(4):1055.
CAS PubMed Central Google Scholar
Camilo V, Sugiyama T, Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2017;22(Suppl):1.
Cardos IA, Zaha DC, Sindhu RK, Cavalu S. Revisiting therapeutic strategies for H. pylori treatment in the context of antibiotic resistance focus on alternative and complementary therapies. Molecules. 2021;26(19):6078.
CAS PubMed PubMed Central Google Scholar
Varghese R, Dalvi YB. Natural products as anticancer agents. Curr Drug Targets. 2021;22(11):1272–87.
Winand L, Sester A, Nett M. Bioengineering of anti-inflammatory natural products. ChemMedChem. 2021;16(5):767–76.
El-Tantawy WH. Natural products for the management of hyperuricaemia and gout: a review. Arch Physiol Biochem. 2021;127(1):61–72.
Zhang S, Li L, Chen W, Xu S, Feng X, Zhang L. Natural products: the role and mechanism in low-density lipoprotein oxidation and atherosclerosis. Phytother Res. 2021;35(6):2945–67.
Boozari M, Hosseinzadeh H. Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies. Phytother Res. 2021;35(2):864–76.
Sadeer NB, Mahomoodally MF. Antibiotic potentiation of natural products: a promising target to fight pathogenic bacteria. Curr Drug Targets. 2021;22(5):555–72.
Yuan S, Gopal JV, Ren S, Chen L, Liu L, Gao Z. Anticancer fungal natural products: mechanisms of action and biosynthesis. Eur J Med Chem. 2020;202: 112502.
Wang H. Talk shallowly that on the clinical application of Tibetan medicine Zuozhu Daxi. Chin J Ethnomed and Ethnopharm. 2014;23:4–5.
Shen F, Li X, Qi D, Jiang H, Guo Z, Chen P. Relationship between the genotypes of Helicobacter pylori in fection and gastroin testinal diseases. Chin J Nosocomiology. 2022;32(3):417–21.
Bertheloot D, Latz E. HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins. Cell Mol Immunol. 2017;14(1):43–64.
Zeng B, Chen C, Yi Q, et al. N-terminal region of Helicobacter pylori CagA induces IL-8 production in gastric epithelial cells via the β1 integrin receptor. J Med Microbiol. 2020;69(3):457–64.
Suganuma M, Watanabe T, Sueoka E, Lim IK, Fujiki H. Role of TNF-α-inducing protein secreted by helicobacter pylori as a tumor promoter in gastric cancer and emerging preventive strategies. Toxins. 2021;13(3):181.
CAS PubMed PubMed Central Google Scholar
Suarez G, Romero-Gallo J, Piazuelo MB, et al. Nod1 imprints inflammatory and carcinogenic responses toward the gastric pathogen helicobacter pylori. Cancer Res. 2019;79(7):1600–11.
CAS PubMed PubMed Central Google Scholar
Figueiredo CA, Marques CR, Costa Rdos S, da Silva HB, Alcantara-Neves NM. Cytokines, cytokine gene polymorphisms and Helicobacter pylori infection: friend or foe? World J Gastroenterol. 2014;20(18):5235–43.
PubMed PubMed Central Google Scholar
Chen Y, Wang X, Yu Y, et al. Serum exosomes of chronic gastritis patients infected with Helicobacter pylori mediate IL-1α expression via IL-6 trans-signalling in gastric epithelial cells. Clin Exp Immunol. 2018;194(3):339–49.
CAS PubMed PubMed Central Google Scholar
Cao D, Jiang J, Tsukamoto T, et al. Canolol inhibits gastric tumors initiation and progression through COX-2/PGE2 pathway in K19–C2mE transgenic mice. PLoS ONE. 2015;10(3): e0120938.
PubMed PubMed Central Google Scholar
Gehrmann W, Würdemann W, Plötz T, Jörns A, Lenzen S, Elsner M. Antagonism between saturated and unsaturated fatty acids in ROS mediated lipotoxicity in rat insulin-producing cells. Cell Physiol Biochem. 2015;36(3):852–65.
Trommer S, Leimert A, Bucher M, Schumann J. Polyunsaturated fatty acids induce ROS synthesis in microvascular endothelial cells. Adv Exp Med Biol. 2018;1072:393–7.
Sun P, Zhou Q, Monroig Ó, et al. Cloning and functional characterization of an elovl4-like gene involved in the biosynthesis of long-chain polyunsaturated fatty acids in the swimming crab Portunus trituberculatus. Comp Biochem Physiol B Biochem Mol Biol. 2020;242: 110408.
Duan S, Zhang M, Li J, et al. Uterine metabolic disorder induced by silica nanoparticles: biodistribution and bioactivity revealed by labeling with FITC. J Nanobiotechnology. 2021;19(1):62.
CAS PubMed PubMed Central Google Scholar
Li Z, Lu S, Cui K, et al. Fatty acid biosynthesis and transcriptional regulation of Stearoyl-CoA Desaturase 1 (SCD1) in buffalo milk. BMC Genet. 2020;21(1):23.
CAS PubMed PubMed Central Google Scholar
Vasireddy V, Sharon M, Salem N Jr, Ayyagari R. Role of ELOVL4 in fatty acid metabolism. Adv Exp Med Biol. 2008;613:283–90.
Yang Y, Chen Z, Zhou L, et al. In silico development and validation of a novel glucose and lipid metabolism-related gene signature in gastric cancer. Transl Cancer Res. 2022;11(7):1977–93.
CAS PubMed PubMed Central Google Scholar
Wang F, Wu J, Qiu Z, et al. ACOT1 expression is associated with poor prognosis in gastric adenocarcinoma. Hum Pathol. 2018;77:35–44.
Raeisi M, Hassanbeigi L, Khalili F, Kharrati-Shishavan H, Yousefi M, Mehdizadeh A. Stearoyl-CoA desaturase 1 as a therapeutic target for cancer: a focus on hepatocellular carcinoma. Mol Biol Rep. 2022;49(9):8871–82.
Wang C, Shi M, Ji J, et al. Stearoyl-CoA desaturase 1 (SCD1) facilitates the growth and anti-ferroptosis of gastric cancer cells and predicts poor prognosis of gastric cancer. Aging. 2020;12(15):15374–91.
CAS PubMed PubMed Central Google Scholar
Huang F, Ren W, Yang G. Clinical observation on therapeutic efficiency of tibean medicine used in treating atrophic gastritis. Chin J of Ethnic Med. 2000;6(1):10–2.
Yu G, Tan Y. Clinical observation of combined treatment of Helicobacter pylori positive peptic ulcer with Zuozhu-Daxi. Chin J Adv Med Educ. 2012;35(z2):61–2.
Hu M, Zhou H, Wang M, Chen C, Du Y. Recent development of study on mongolian medicine gypsum fibrosum. J Med Pharm of Chin Mnorities. 2014;20(9):34–6.
Li H, Wang Q, Chen P, Zhou C, Zhang X, Chen L. Ursodeoxycholic acid treatment restores gut microbiota and alleviates liver inflammation in non-alcoholic steatohepatitic mouse model. Front Pharmacol. 2021;12: 788558.
CAS PubMed PubMed Central Google Scholar
Chen X, Mellon RD, Yang L, Dong H, Oppenheim JJ, Howard OM. Regulatory effects of deoxycholic acid, a component of the anti-inflammatory traditional Chinese medicine Niuhuang, on human leukocyte response to chemoattractants. Biochem Pharmacol. 2002;63(3):533–41.
留言 (0)